NIH evaluates first investigational vaccine for COVID-19.
NIH clinical trial of investigational vaccine for COVID-19 begins in Seattle
Sharon Brooks
A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, the National Institutes of Health (NIH) reported March 16.
Monday, March 16, 2020
